HUP0004173A2 - Immunszuppresszív szereket tartalmazó, helyileg alkalmazható szemgyógyászati készítmények - Google Patents

Immunszuppresszív szereket tartalmazó, helyileg alkalmazható szemgyógyászati készítmények

Info

Publication number
HUP0004173A2
HUP0004173A2 HU0004173A HUP0004173A HUP0004173A2 HU P0004173 A2 HUP0004173 A2 HU P0004173A2 HU 0004173 A HU0004173 A HU 0004173A HU P0004173 A HUP0004173 A HU P0004173A HU P0004173 A2 HUP0004173 A2 HU P0004173A2
Authority
HU
Hungary
Prior art keywords
immunosuppressive agents
weight
ethanediyl
isocyanato
hydro
Prior art date
Application number
HU0004173A
Other languages
English (en)
Hungarian (hu)
Inventor
Alexandr Jegorov
Vladimír Matha
Josef Stuchlík
Milan Stuchlík
Original Assignee
Galena, A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galena, A.S. filed Critical Galena, A.S.
Publication of HUP0004173A2 publication Critical patent/HUP0004173A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
HU0004173A 1997-12-30 1998-12-17 Immunszuppresszív szereket tartalmazó, helyileg alkalmazható szemgyógyászati készítmények HUP0004173A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ19974237A CZ287497B6 (cs) 1997-12-30 1997-12-30 Topické oční přípravky s imunosupresivními látkami
PCT/CZ1998/000054 WO1999034830A1 (en) 1997-12-30 1998-12-17 Topical ophthalmic preparations containing immunosuppressive agents

Publications (1)

Publication Number Publication Date
HUP0004173A2 true HUP0004173A2 (hu) 2001-08-28

Family

ID=5467853

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004173A HUP0004173A2 (hu) 1997-12-30 1998-12-17 Immunszuppresszív szereket tartalmazó, helyileg alkalmazható szemgyógyászati készítmények

Country Status (12)

Country Link
EP (1) EP1058560A1 (ja)
JP (1) JP2002500200A (ja)
AU (1) AU1481399A (ja)
BG (1) BG104558A (ja)
CA (1) CA2317010A1 (ja)
CZ (1) CZ287497B6 (ja)
HR (1) HRP20000258A2 (ja)
HU (1) HUP0004173A2 (ja)
NO (1) NO20003344D0 (ja)
PL (1) PL341604A1 (ja)
SK (1) SK284246B6 (ja)
WO (1) WO1999034830A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ513111A (en) * 1998-12-24 2003-10-31 R Tech Ueno Ltd Agent for treating visual cell function disorder
US6864232B1 (en) 1998-12-24 2005-03-08 Sucampo Ag Agent for treating visual cell function disorder
AR035293A1 (es) * 2001-08-23 2004-05-05 Novartis Ag Composicion oftalmica.
DK1539157T3 (da) 2002-09-18 2013-10-07 Univ Pennsylvania Fremgangsmåde til hæmning af choroidal neovaskularisering
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
US7083802B2 (en) 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
BRPI0607606B1 (pt) 2005-02-09 2021-06-22 Santen Pharmaceutical, Co., Ltd. Formulação líquida
PL1904056T3 (pl) 2005-07-18 2009-09-30 Minu Llc Zastosowanie makrolidu do przywracania czucia rogówkowego
EP2001438A2 (en) 2006-02-09 2008-12-17 Macusight, Inc. Stable formulations, and methods of their preparation and use
JP5506378B2 (ja) 2006-03-23 2014-05-28 参天製薬株式会社 血管透過性に関連する疾患または病気のための製剤および方法
EP2948134B1 (en) 2013-01-24 2020-03-04 Palvella Therapeutics, Inc. Compositions for transdermal delivery of mtor inhibitors
WO2014153733A1 (en) * 2013-03-27 2014-10-02 Comprehensive Drug Enterprises, Ltd. Ophthalmic composition, method for preparing the same, and use of the same
CN109071750B (zh) 2016-03-08 2022-08-02 生活实验公司 持久化妆品组合物
CA3049402A1 (en) 2017-01-06 2018-07-12 Palvella Therapeutics Llc Anhydrous compositions of mtor inhibitors and methods of use
JP7244494B2 (ja) 2017-09-13 2023-03-22 リビング プルーフ インコーポレイテッド 色保護剤組成物
CN111133023B (zh) 2017-09-13 2022-10-18 生活实验公司 持久化妆品组合物
US11000513B2 (en) 2018-07-02 2021-05-11 Palvella Therapeutics, Inc. Anhydrous compositions of mTOR inhibitors and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971800A (en) * 1988-07-08 1990-11-20 The Regents Of The University Of California Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents
US5051260A (en) * 1987-07-16 1991-09-24 The Regents Of The University Of California Method and composition for enhancing the cutaneous penetration of pharmacologically active agents
US5045317A (en) * 1987-07-16 1991-09-03 The Regents Of The University Of California Enhancing the cutaneous penetration of pharmacologically active agents

Also Published As

Publication number Publication date
CZ423797A3 (cs) 1999-07-14
PL341604A1 (en) 2001-04-23
NO20003344L (no) 2000-06-27
WO1999034830A1 (en) 1999-07-15
JP2002500200A (ja) 2002-01-08
NO20003344D0 (no) 2000-06-27
SK171798A3 (en) 1999-10-08
CZ287497B6 (cs) 2000-12-13
CA2317010A1 (en) 1999-07-15
BG104558A (en) 2001-02-28
AU1481399A (en) 1999-07-26
SK284246B6 (sk) 2004-12-01
EP1058560A1 (en) 2000-12-13
HRP20000258A2 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
HUP0004173A2 (hu) Immunszuppresszív szereket tartalmazó, helyileg alkalmazható szemgyógyászati készítmények
MA26859A1 (fr) Forme posologique de medicament commandée par un hydrogel.
EP1380583A3 (de) Bis-Resorcinyl-Triazine und deren Verwendung als Sonnenschutzmittel
CA2169087A1 (en) Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
ES2092699T3 (es) Composicion para tratamiento cosmetico y/o farmaceutico, de larga duracion, de las capas superiores de la epidermis, por una aplicacion topica sobre la piel.
CA2087146A1 (en) Flavour-masked pharmaceutical compositions
HU9402830D0 (en) Topical administration of toremifene and its metabolites
MY105879A (en) Antiplaque antibacterial oral composition
CA2169635A1 (en) Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
CA2165768A1 (en) Thermoplastic elastomeric copolymers and hair and skin care compositionscontaining the same
EP0983994A3 (de) Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
ES2114502A1 (es) Aplicacion de nanoparticulas a base de polimeros hidrofilicos como formas farmaceuticas.
CA2110161A1 (en) Medetomidine preparations for transdermal administration
HUP0104268A2 (hu) Hosszan tartó hatóanyag-kibocsátású fluvasztatin-tartalmú gyógyászati készítmény
CA2299420A1 (en) Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use
FR2729296B1 (fr) Compositions pharmaceutiques comprenant une superoxyde dismutase
CA2066249A1 (en) Estradiol percutaneous administration preparations
EP0392845A3 (en) Solid gel external drug delivery system
AU5673399A (en) Compositions and methods for treating intracellular infections
WO2000074649A3 (en) Ophthalmic histamine compositions and uses thereof
GR3021231T3 (en) Process for preparing stable hydrophilic or ambiphic cream preparations containing vesicular composnents and their use
FR2701847B1 (fr) Compositions pharmaceutiques et cosmétiques à base d'albumine végétale, préparations contenant de telles compositions et procédé de préparation.
CA2113080A1 (en) Topical composition containing penciclovir
WO1998033478A3 (en) Rna- and dna-based active agents in nanoparticles
FR2572932B1 (fr) Medicament insoluble administre localement dans l'oreille